An observational study in Chronic Myeloid Leukemia, sponsored by Assiut University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2026-02-18.
Sponsored by Assiut University · Observational
to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism
to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism and how danger they drugs be
964 studies on the registry are indexed under Leukemia, Myelogenous, Chronic, BCR-ABL Positive; 109 are open to participants now.
This study's planned enrollment of 75 is below the median of 141 across 149 observational studies indexed under Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Browse Leukemia, Myelogenous, Chronic, BCR-ABL Positive studies →Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
CML patients
Exclusion Criteria:
these drugs used in CML only
Change in HbA1c levels in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
Assessment of change in HbA1c levels in CML patients treated with TKIs.
Time frame: Baseline and 3, 6, 9, and 12 months
Change in lipid profile in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
Assessment of changes in lipid profile including total cholesterol, triglycerides, LDL, and HDL in CML patients treated with TKIs.
Time frame: Baseline and 3, 6, 9, and 12 months
No study locations are listed for this record.
Plan to share: No
This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive→
Assiut University